Kantar Health Blog

  • Time Deficits and Silent Killers

    by Lynnette Cooke | May 13, 2015
    Lynnette Cooke
    We’ve all heard hypertension called “the silent killer”: it’s largely asymptomatic but increases the risk of serious and sometimes fatal conditions such as heart attack and stroke. Making lifestyle changes can significantly lower our blood pressure and risk of cardiovascular disease, but all too often we find ourselves in a time crunch where our health takes a backseat to other obligations.
    Continue Reading > | Go comment! | Share
  • Stephanie Hawthorne
    The annual meeting of the American Society of Clinical Oncology (ASCO) is nearing, and Kantar Health has identified several pivotal abstracts that will be presented. The 2015 ASCO annual meeting promises to be packed with the latest data and trends from the world of oncology, and the meeting has the potential to alter treatment practices in several tumor types.
    Continue Reading > | Go comment! | Share
  • Lynnette Cooke
    Like a lot of women, I'm acting as my family's Chief Medical Officer.
    Continue Reading > | Go comment! | Share
  • Arnold DuBell
    Oncology Conference Insight: AACR 2015 --- Recent progress in the development of novel therapeutic agents to combat melanoma has been tremendous. Immune checkpoint inhibition and targeted inhibition of BRAF and MEK are two therapeutic approaches that have significantly improved survival for patients with advanced melanoma. Since 2011, the FDA has approved three checkpoint inhibitors.
    Continue Reading > | Go comment! | Share
  • Building a community one device at a time

    by Brian Mondry | Mar 17, 2015
    Brian Mondry
    We have already seen connectivity in action in the general health and wellness space with Nike, Fitbit and MyFitnessPal providing community extensions for their devices and mobile apps. But the chronic disease space is where the biggest impact will be realized.
    Continue Reading > | Go comment! | Share